 | | | | GENEVA (Reuters) - Democratic Republic of Congo faces a "very high" public health risk from Ebola because the disease has been confirmed in a patient in a big city, the World Health Organization (WHO) said on Friday, raising its assessment from "high" previously. | | |
| | | (Reuters) - Amgen Inc won U.S. Food and Drug Administration approval on Thursday for the first drug in a new class designed to prevent migraine headaches in adults. | | |
| | | (Reuters) - The U.S. Food and Drug Administration on Thursday listed a number of drugmakers it said could be improperly blocking access to their medicines in order to delay generic competition. | | |
| | | (Reuters) - Fire investigators are examining whether the battery in an electronic cigarette triggered a small explosion that killed a man in Florida this month, sending fragments of the vape device into his skull, in what may be the first such fatality in the country. | | |
| | | (Reuters Health) - Girls who go through puberty early may be more likely than peers who mature later to be involved in bullying at school - either as victims or perpetrators, a recent study suggests. | | |
| | | BERLIN (Reuters) - Beer cannot be marketed as beneficial, a German top court ruled on Thursday after a consumer rights group sued a brewery on the basis that its advertisement falsely suggested the beer had health benefits. | | |
| | | (Reuters Health) - Public reporting of outcomes for a common procedure to clear blocked arteries was supposed to improve quality, but some doctors say it hasn't delivered on the goal of enhancing patient care. | | |
| | | JOHANNESBURG (Reuters) - The death toll from the world's largest ever outbreak of the food-borne disease listeria has risen to 204, but the number of new cases has declined sharply after products were recalled, South African authorities said on Thursday. | | |
| | | NEW YORK (Reuters) - Allergan Inc was sued on Wednesday by four large U.S. retailers that accused the drugmaker of antitrust violations for trying to stop rivals from selling generic versions of Restasis, its medication to treat dry-eye disease. | | |
| | | (Reuters) - The U.S. Food and Drug Administration on Wednesday approved https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm607884.htm the first non-opioid drug that will help reduce symptoms of opioid withdrawal in adults. | | |
|
| |
